Morphic (MORF) Insider Trading & Ownership → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free MORF Stock Alerts $29.23 -3.22 (-9.92%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Morphic (NASDAQ:MORF) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$49,440.00Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$4.04 M MORF Insider Buying and Selling by Quarter Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… Morphic Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/16/2024Bruce RogersPresidentSell6,314$27.49$173,571.86 1/16/2024Marc SchegerinCFOSell6,041$27.49$166,067.09 1/16/2024Praveen P TipirneniCEOSell13,923$27.49$382,743.27 1/16/2024Robert E Farrell JrCAOSell5,089$27.49$139,896.61 1/16/2024William DevaulGeneral CounselSell4,509$27.49$123,952.41 11/13/2023Joseph P SlatteryDirectorBuy2,400$20.60$49,440.00 The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.9/7/2023Marc SchegerinCFOSell20,000$54.34$1,086,800.00 8/1/2023Praveen P TipirneniCEOSell3,597$57.04$205,172.88 7/3/2023Praveen P TipirneniCEOSell3,597$57.04$205,172.88 6/12/2023Praveen P TipirneniCEOSell840$63.01$52,928.40 6/7/2023William DevaulGeneral CounselSell7,756$60.05$465,747.80 6/1/2023Praveen P TipirneniCEOSell3,597$57.14$205,532.58 5/23/2023Robert E Farrell JrCAOSell10,000$60.00$600,000.00 5/23/2023William DevaulGeneral CounselSell3,802$60.03$228,234.06 (Data available from 1/1/2013 forward) MORF Insider Trading Activity - Frequently Asked Questions Who is on Morphic's Insider Roster? The list of insiders at Morphic includes Amir Nashat, Bruce Rogers, Joseph P Slattery, Marc Schegerin, Peter Linde, Praveen P Tipirneni, Robert E Farrell Jr, Robert E. Farrell, Jr., Timothy A Springer, and William Devaul. Learn more on insiders at MORF. What percentage of Morphic stock is owned by insiders? 28.10% of Morphic stock is owned by insiders. Learn more on MORF's insider holdings. Which Morphic insiders have been buying company stock? The following insiders have purchased MORF shares in the last 24 months: Joseph P Slattery ($49,440.00), and Timothy A Springer ($47,250,000.00). How much insider buying is happening at Morphic? Insiders have purchased a total of 1,052,400 MORF shares in the last 24 months for a total of $47,299,440.00 bought. Which Morphic insiders have been selling company stock? The following insiders have sold MORF shares in the last 24 months: Bruce Rogers ($2,634,432.00), Marc Schegerin ($6,289,519.19), Praveen P Tipirneni ($2,703,298.29), Robert E Farrell Jr ($2,600,222.85), and William Devaul ($853,740.74). How much insider selling is happening at Morphic? Insiders have sold a total of 317,733 Morphic shares in the last 24 months for a total of $15,081,213.07 sold. More Insider Trading Tools from MarketBeat Related Companies: Protagonist Therapeutics Insider Buying Akero Therapeutics Insider Buying Xencor Insider Buying Day One Biopharmaceuticals Insider Buying Dynavax Technologies Insider Buying Kiniksa Pharmaceuticals Insider Buying Arcus Biosciences Insider Buying Kura Oncology Insider Buying ANI Pharmaceuticals Insider Buying Avadel Pharmaceuticals Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:MORF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressUrgent Nvidia WarningAltimetry"The Biggest Drug Ever" Is ComingBehind the MarketsProtect Your Bank Account Before It’s Too LateWeiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding Morphic Holding, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.